277 related articles for article (PubMed ID: 37539726)
21. N6-methyladenosine modification and metabolic reprogramming of digestive system malignancies.
Cai X; Liang C; Zhang M; Xu Y; Weng Y; Li X; Yu W
Cancer Lett; 2022 Sep; 544():215815. PubMed ID: 35798087
[TBL] [Abstract][Full Text] [Related]
22. METTL3‑mediated m6A modification of Bcl‑2 mRNA promotes non‑small cell lung cancer progression.
Zhang Y; Liu S; Zhao T; Dang C
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34132367
[TBL] [Abstract][Full Text] [Related]
23. Functions, mechanisms, and therapeutic implications of METTL14 in human cancer.
Guan Q; Lin H; Miao L; Guo H; Chen Y; Zhuo Z; He J
J Hematol Oncol; 2022 Feb; 15(1):13. PubMed ID: 35115038
[TBL] [Abstract][Full Text] [Related]
24. Interactions, localization, and phosphorylation of the m
Schöller E; Weichmann F; Treiber T; Ringle S; Treiber N; Flatley A; Feederle R; Bruckmann A; Meister G
RNA; 2018 Apr; 24(4):499-512. PubMed ID: 29348140
[No Abstract] [Full Text] [Related]
25. The role of RNA methyltransferase METTL3 in gynecologic cancers: Results and mechanisms.
Zhang Y; Zhang N
Front Pharmacol; 2023; 14():1156629. PubMed ID: 37007040
[TBL] [Abstract][Full Text] [Related]
26. METTL3-mediated RNA m6A Hypermethylation Promotes Tumorigenesis and GH Secretion of Pituitary Somatotroph Adenomas.
Chang M; Wang Z; Gao J; Yang C; Feng M; Niu Y; Tong WM; Bao X; Wang R
J Clin Endocrinol Metab; 2022 Jan; 107(1):136-149. PubMed ID: 34491359
[TBL] [Abstract][Full Text] [Related]
27. The N6-methyladenosine METTL3 regulates tumorigenesis and glycolysis by mediating m6A methylation of the tumor suppressor LATS1 in breast cancer.
Xu Y; Song M; Hong Z; Chen W; Zhang Q; Zhou J; Yang C; He Z; Yu J; Peng X; Zhu Q; Li S; Ji K; Liu M; Zuo Q
J Exp Clin Cancer Res; 2023 Jan; 42(1):10. PubMed ID: 36609396
[TBL] [Abstract][Full Text] [Related]
28. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM
Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881
[TBL] [Abstract][Full Text] [Related]
29. Upregulation of METTL3 expression and m6A RNA methylation in placental trophoblasts in preeclampsia.
Gu Y; Chu X; Morgan JA; Lewis DF; Wang Y
Placenta; 2021 Jan; 103():43-49. PubMed ID: 33070036
[TBL] [Abstract][Full Text] [Related]
30. The m6A methyltransferase METTL3 promotes osteosarcoma progression by regulating the m6A level of LEF1.
Miao W; Chen J; Jia L; Ma J; Song D
Biochem Biophys Res Commun; 2019 Aug; 516(3):719-725. PubMed ID: 31253399
[TBL] [Abstract][Full Text] [Related]
31. METTL3/YTHDF2 m6A axis promotes the malignant progression of bladder cancer by epigenetically suppressing RRAS.
Chen JX; Chen DM; Wang D; Xiao Y; Zhu S; Xu XL
Oncol Rep; 2023 May; 49(5):. PubMed ID: 36960869
[TBL] [Abstract][Full Text] [Related]
32. A cancer-associated METTL14 mutation induces aberrant m6A modification, affecting tumor growth.
Miyake K; Costa Cruz PH; Nagatomo I; Kato Y; Motooka D; Satoh S; Adachi Y; Takeda Y; Kawahara Y; Kumanogoh A
Cell Rep; 2023 Jul; 42(7):112688. PubMed ID: 37355987
[TBL] [Abstract][Full Text] [Related]
33. Dynamic assembly of the mRNA m6A methyltransferase complex is regulated by METTL3 phase separation.
Han D; Longhini AP; Zhang X; Hoang V; Wilson MZ; Kosik KS
PLoS Biol; 2022 Feb; 20(2):e3001535. PubMed ID: 35143475
[TBL] [Abstract][Full Text] [Related]
34. A Mass Spectrometric Assay of METTL3/METTL14 Methyltransferase Activity.
Buker SM; Gurard-Levin ZA; Wheeler BD; Scholle MD; Case AW; Hirsch JL; Ribich S; Copeland RA; Boriack-Sjodin PA
SLAS Discov; 2020 Apr; 25(4):361-371. PubMed ID: 31585521
[TBL] [Abstract][Full Text] [Related]
35. METTL14 is decreased and regulates m
He H; Zhang Q; Liao J; Lei J; Luo M; Huang J; Chen M; Shen Y; Wang J; Xu P; Xiao Y
J Neurochem; 2023 Aug; 166(3):609-622. PubMed ID: 37309980
[TBL] [Abstract][Full Text] [Related]
36. Alphaherpesvirus US3 protein-mediated inhibition of the m6A mRNA methyltransferase complex.
Jansens RJJ; Verhamme R; Mirza AH; Olarerin-George A; Van Waesberghe C; Jaffrey SR; Favoreel HW
Cell Rep; 2022 Jul; 40(3):111107. PubMed ID: 35858564
[TBL] [Abstract][Full Text] [Related]
37. The N
Dorn LE; Lasman L; Chen J; Xu X; Hund TJ; Medvedovic M; Hanna JH; van Berlo JH; Accornero F
Circulation; 2019 Jan; 139(4):533-545. PubMed ID: 30586742
[TBL] [Abstract][Full Text] [Related]
38. RNA secondary structure dependence in METTL3-METTL14 mRNA methylation is modulated by the N-terminal domain of METTL3.
Meiser N; Mench N; Hengesbach M
Biol Chem; 2020 Nov; 402(1):89-98. PubMed ID: 33544495
[No Abstract] [Full Text] [Related]
39. N6-methyladenosine methyltransferase plays a role in hypoxic preconditioning partially through the interaction with lncRNA H19.
Su Y; Xu R; Zhang R; Qu Y; Zuo W; Ji Z; Geng H; Pan M; Ma G
Acta Biochim Biophys Sin (Shanghai); 2020 Dec; 52(12):1306-1315. PubMed ID: 33197240
[TBL] [Abstract][Full Text] [Related]
40. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]